assessing the role of car-t in cll
Published 4 years ago • 232 plays • Length 14:54Download video MP4
Download video MP3
Similar videos
-
2:04
the evolving role of car-t therapy in cll
-
2:17
the challenges of implementing car-t therapy in cll
-
1:49
car-t cell approaches in cll: current progress & future directions
-
1:28
assessment of car-t and tcr adverse events
-
1:25
where are we with car-t in cll?
-
3:38
the potential of car-t in cll
-
1:39
the role of myeloid cells in car-t cell therapy
-
58:59
car-t cell therapy: current uses and future possibilities
-
1:00:52
the latest advancements in the treatment of acute myeloid leukaemia (aml) webinar
-
7:26
the truth about cll symptoms
-
37:22
eha 2024 recap: optimizing the relapsed/refractory cll treatment pathway
-
1:10
response to car t-cell treatment in cll patients
-
2:20
car-t assessment in the ambulatory care setting
-
1:46
car-t as a next-generation therapy for cll
-
3:39
car t-cells in cll: the current landscape
-
1:51
challenges of car-t therapy for cll
-
13:25
cll and car-t
-
1:09
car-t for cll
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
1:59
a potential role for car-t therapy in patients with high-risk cll
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
4:07
horizon scan: cll and car-t